CNS Pharmaceuticals Inc.

CNSP | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.24

+$0.02 (+0.41%)

At close: Sep 22, 2026, 4:00 PM ET

$5.12

-$0.12 (-2.29%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.41%

(1D)

Rating

Updated: Aug 29, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $7.66M

1D Range

5 5.25

52W Range

1.90 10.59

Valuation (TTM)

PE -0.22

PB 0.42

EV/EBITDA 0.74

Valuation (NTM)

Forward PE N/A

Forward PEG -0.37

Price Target $0.50

Cash Flow

FCF Yield -176.3%

SBC Adj. FCF Yield -177.7%

SBC Impact -0.8%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 149.5% | 92.0%

FCF 3Y | 5Y -8.9% | -8.7%

Returns

ROA -76.1%

ROE -204.3%

ROIC -92.9%

Financial Health

Net Cash

$19.99M

Current Ratio 5.86

Interest Coverage -1,131.57

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primar...

Sector Healthcare

Industry Biotechnology

Employees 8

IPO Date Nov 7, 2019

Website www.cnspharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.